EVO is a globally trusted and tested procedure. According to a STAAR patient survey, 99.4% of patients would have the EVO procedure again.6 Over 1,000,000 EVO ICL lenses have been implanted around the world. And now the EVO ICL has been confirmed by the U.S. FDA to be a safe and effective treatment of moderate to high nearsightedness with or without astigmatism for U.S. patients.